Cargando…
Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
Recent evidence indicates that metformin therapy may be associated with a decreased colorectal adenoma/colorectal cancer risk in type 2 diabetes patients. However, results are not consistent. We therefore performed a systematic review and meta-analysis to assess the association between metformin the...
Autores principales: | Liu, Feifei, Yan, Lijing, Wang, Zhan, Lu, Yuanan, Chu, Yuanyuan, Li, Xiangyu, Liu, Yisi, Rui, Dongsheng, Nie, Shaofa, Xiang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362542/ https://www.ncbi.nlm.nih.gov/pubmed/27926481 http://dx.doi.org/10.18632/oncotarget.13762 |
Ejemplares similares
-
Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies
por: Yu, Feifei, et al.
Publicado: (2016) -
Meta-Analysis of the Association between Insulin-Like Growth Factor Binding Protein 3 Genetic Polymorphisms and Colorectal Cancer Susceptibility
por: Xiang, Hao, et al.
Publicado: (2013) -
Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis
por: Hou, Yi-Chao, et al.
Publicado: (2016) -
Inhibitory Effect of Metformin Therapy on the Incidence of Colorectal Advanced Adenomas in Patients With Diabetes
por: Kim, Yo Han, et al.
Publicado: (2015) -
Development of a global health bachelor curriculum in China: a Delphi study
por: Guan, Li, et al.
Publicado: (2019)